Efficacy and safety of twice-yearly depemokimab in patients with chronic rhinosinusitis with nasal polyps (crswnp): the phase iii randomized, double-blind, placebo-controlled replicate ANCHOR-1/2 Trials Meeting Abstract

publication date

  • September 1, 2025

webpage

published in

start page

  • 550

end page

  • 550

volume

  • 48

issue

  • 9